首页> 美国卫生研究院文献>Frontiers in Public Health >Who Owns the Data? Open Data for Healthcare
【2h】

Who Owns the Data? Open Data for Healthcare

机译:谁拥有数据?开放医疗数据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Research on large shared medical datasets and data-driven research are gaining fast momentum and provide major opportunities for improving health systems as well as individual care. Such open data can shed light on the causes of disease and effects of treatment, including adverse reactions side-effects of treatments, while also facilitating analyses tailored to an individual’s characteristics, known as personalized or “stratified medicine.” Developments, such as crowdsourcing, participatory surveillance, and individuals pledging to become “data donors” and the “quantified self” movement (where citizens share data through mobile device-connected technologies), have great potential to contribute to our knowledge of disease, improving diagnostics, and delivery of ­healthcare and treatment. There is not only a great potential but also major concerns over privacy, confidentiality, and control of data about individuals once it is shared. Issues, such as user trust, data privacy, transparency over the control of data ownership, and the implications of data analytics for personal privacy with potentially intrusive inferences, are becoming increasingly scrutinized at national and international levels. This can be seen in the recent backlash over the proposed implementation of care.data, which enables individuals’ NHS data to be linked, retained, and shared for other uses, such as research and, more controversially, with businesses for commercial exploitation. By way of contrast, through increasing popularity of social media, GPS-enabled mobile apps and tracking/wearable devices, the IT industry and MedTech giants are pursuing new projects without clear public and policy discussion about ownership and responsibility for user-generated data. In the absence of transparent regulation, this paper addresses the opportunities of Big Data in healthcare together with issues of responsibility and accountability. It also aims to pave the way for public policy to support a balanced agenda that safeguards personal information while enabling the use of data to improve public health.
机译:大型共享医学数据集的研究和以数据为驱动的研究正在迅速发展,并为改善卫生系统和个人护理提供了重大机遇。这样的开放数据可以阐明疾病的原因和治疗效果,包括治疗的不良反应副作用,同时还可以根据个人特点量身定制分析,称为个性化或“分层医学”。诸如众包,参与性监控以及个人承诺成为“数据捐赠者”和“量化自我”运动(公民通过移动设备连接技术共享数据)等发展,具有极大的潜力,有助于我们了解疾病,改善疾病诊断以及提供医疗保健和治疗。数据共享后,不仅存在巨大的潜力,而且对于隐私,机密性和有关个人数据的控制也存在重大问题。用户信任,数据隐私,数据所有权控制的透明性以及数据分析对具有潜在干扰性推论的个人隐私的影响等问题在国家和国际层面上越来越受到关注。可以从最近对care.data实施建议的强烈反对中看出这一点,该功能使个人的NHS数据可以链接,保留和共享,以用于其他用途,例如研究,以及与商业开发企业有关的争议更大。相比之下,通过社交媒体,支持GPS的移动应用程序和跟踪/可穿戴设备的日益普及,IT行业和MedTech巨头正在寻求新的项目,而没有就用户生成数据的所有权和责任进行明确的公开和政策讨论。在缺乏透明监管的情况下,本文将探讨大数据在医疗保健领域的机会以及责任和问责制问题。它还旨在为公共政策支持平衡的议程铺平道路,该议程既可以保护个人信息,又可以使用数据来改善公共卫生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号